Skip to main content
SpringerLink
Log in

Approach to the Atypical Wound

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

The heterogeneity of atypical wounds can present diagnostic and therapeutic challenges; however, as the prevalence of atypical wounds grows worldwide, prompt and accurate management is increasingly an essential skill for dermatologists. Addressing the underlying cause of an atypical wound is critical for successful outcomes. An integrated approach with a focus on pain management and patient engagement is recommended to facilitate enduring wound closure. Advances in treatment, in addition to further research and clinical training, are necessary to address the expanding burden of atypical wounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16
Fig. 17
Fig. 18

Similar content being viewed by others

References

  1. Isoherranen K, O'Brien JJ, Barker J, et al. Atypical wounds. Best clinical practice and challenges. J Wound Care. 2019;28(Sup6):S1–92. https://doi.org/10.12968/jowc.2019.28.Sup6.S1.

    Article  PubMed  Google Scholar 

  2. Shelling ML, Federman DG, Kirsner RS. Clinical approach to atypical wounds with a new model for understanding hypertensive ulcers. Arch Dermatol. 2010;146(9):1026–9.

    Article  PubMed  Google Scholar 

  3. Van Driessche FKR. Atypical wounds. In: Ayello EA, Barnoski S. Wound care essentials. Philadelphia: Lippincott Williams & Wilkins; 2016.

    Google Scholar 

  4. Janowska A, Dini V, Oranges T, et al. Atypical ulcers: diagnosis and management. Clin Interv Aging. 2019;14:2137–43. https://doi.org/10.2147/CIA.S231896.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hoffman MD. Atypical ulcers. Dermatol Ther. 2013;26(3):222–35.

    Article  PubMed  Google Scholar 

  6. de Araujo TKR. Atypical wounds. In: Ayello EA, Barnoski S. Wound care essentials. Philadelphia: Lippincott Williams & Wilkins; 2004.

    Google Scholar 

  7. Mahmoudi M, Gould L. Opportunities and challenges of the management of chronic wounds: a multidisciplinary viewpoint. Chronic Wound Care Manag Res. 2020;7:27–36.

    Article  Google Scholar 

  8. Huang Y, Mao B, Ni P, et al. Investigation on the status and determinants of caregiver burden on caring for patients with chronic wound. Adv Wound Care (New Rochelle). 2019;8(9):429–37. https://doi.org/10.1089/wound.2018.0873.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Falanga V, Isseroff RR, Soulika AM, et al. Chronic wounds. Nat Rev Dis Primers. 2022;8(1):50. https://doi.org/10.1038/s41572-022-00377-3.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Nussbaum SR, Carter MJ, Fife CE, et al. An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds. Value Health. 2018;21(1):27–32. https://doi.org/10.1016/j.jval.2017.07.007.

    Article  PubMed  Google Scholar 

  11. Afsaneh Alavi HIM. Local wound care for dermatologists. 1st ed. Updates in clinical dermatology. Cham: Springer; 2020.

    Book  Google Scholar 

  12. Solowiej K, Mason V, Upton D. Review of the relationship between stress and wound healing: part 1. J Wound Care. 2009;18(9):357–66.

    Article  CAS  PubMed  Google Scholar 

  13. Tiri H, Huilaja L, Jokelainen J, et al. Women with hidradenitis suppurativa have an elevated risk of suicide. J Invest Dermatol. 2018;138(12):2672–74. https://doi.org/10.1016/j.jid.2018.06.171.

    Article  CAS  PubMed  Google Scholar 

  14. Woo K, Jimenez C. Quality of life and chronic wound care. In: Ayello EA, Barnoski S. Wound care essentials. Philadelphia: Lippincott Williams & Wilkins; 2016.

    Google Scholar 

  15. Hopman WM, Harrison MB, Coo H, et al. Associations between chronic disease, age and physical and mental health status. Chronic Dis Can. 2009;29(3):108–16.

    Article  CAS  PubMed  Google Scholar 

  16. Shanmugam VK, Schilling A, Germinario A, et al. Prevalence of immune disease in patients with wounds presenting to a tertiary wound healing centre. Int Wound J. 2012;9(4):403–11.

    Article  PubMed  Google Scholar 

  17. Powers JG, Higham C, Broussard K, et al. Wound healing and treating wounds: Chronic wound care and management. J Am Acad Dermatol. 2016;74(4):607–25; quiz 25–6.

    Article  PubMed  Google Scholar 

  18. Tang JC, Vivas A, Rey A, et al. Atypical ulcers: wound biopsy results from a university wound pathology service . Ostomy Wound Manage. 2012;58(6):20–2, 4, 6–9.

    PubMed  Google Scholar 

  19. Haynes D, Hammer P, Malachowski SJ, et al. Characterisation and diagnosis of ulcers in inpatient dermatology consultation services: A multi-centre study. Int Wound J. 2019;16(6):1440–4.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hwang JM. Time is tissue. Want to save millions in wound care? Start early: a QI project to expedite referral of high-risk wound care patients to specialised care. BMJ Open Qual. 2023;12(1):e002206. https://doi.org/10.1136/bmjoq-2022-002206.

  21. Virkkala J, Polet S, Jokelainen J, et al. Clinical characteristics and comorbidities of the most common atypical wounds in Northern Finland in 1996–2019: A retrospective registry study. Health Sci Rep. 2022;5(5):e864.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ruiz ES, Ingram A, Landriscina A, et al. Identifying an education gap in wound care training in united states dermatology. J Drugs Dermatol. 2015;14(7):716–20.

    PubMed  Google Scholar 

  23. Erickson KM, Reese AM, Ortega-Loayza AG. Gap of knowledge in diagnosis of pyoderma gangrenosum in clinical specialties education. Diagnosis (Berl). 2021;8(4):421–4.

    Article  PubMed  Google Scholar 

  24. Shakshouk H, Lehman JS, Wu B, et al. Limb amputation in patients with pyoderma gangrenosum: a multi-institutional case series. Arch Dermatol Res. 2023;315(5):1443–8.

    PubMed  Google Scholar 

  25. Zahoor S, Siddique S, Mahboob HM. An unusual presentation of polyarteritis nodosa: A case report. Reumatol Clin (Engl Ed). 2020. https://doi.org/10.1016/j.reuma.2020.08.008.

  26. Xu A, Balgobind A, Strunk A, et al. Prevalence estimates for pyoderma gangrenosum in the United States: An age- and sex-adjusted population analysis. J Am Acad Dermatol. 2020;83(2):425–9.

    Article  PubMed  Google Scholar 

  27. Braswell SF, Kostopoulos TC, Ortega-Loayza AG. Pathophysiology of pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol. 2015;73(4):691–8.

    Article  CAS  PubMed  Google Scholar 

  28. Kridin K, Cohen AD, Amber KT. Underlying systemic diseases in pyoderma gangrenosum: a systematic review and meta-analysis. Am J Clin Dermatol. 2018;19(4):479–87.

    Article  PubMed  Google Scholar 

  29. Al Ghazal P, Körber A, Klode J, et al. Investigation of new co-factors in 49 patients with pyoderma gangrenosum. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2012;10(4):251–6.

    Article  PubMed  Google Scholar 

  30. Moelleken M, Erfurt-Berge C, Ronicke M, et al. Predilection sites of pyoderma gangrenosum: Retrospective study of 170 clearly diagnosed patients. Int Wound J. 2023;20(10):4227–34. https://doi.org/10.1111/iwj.14323.

  31. Zhao H, Larson C, Schepergerdes BJ, Diefendorf CM, Ortega-Loayza AG, Mostaghimi A. Hundreds of inconsistencies in the nomenclature of pyoderma gangrenosum: The need to harmonise terminology for phenotypes. Int Wound J. 2024;21(1):e14357. https://doi.org/10.1111/iwj.14357.

  32. André MFJ, et al. Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature. Medicine (Baltimore). 2007;86(3):145–61.

    Article  PubMed  Google Scholar 

  33. Haag C, Hansen T, Hajar T, et al. Comparison of three diagnostic frameworks for pyoderma gangrenosum. J Invest Dermatol. 2021;141(1):59–63.

    Article  CAS  PubMed  Google Scholar 

  34. Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum: a review. J Cutan Pathol. 2003;30(2):97–107.

    Article  PubMed  Google Scholar 

  35. Binus AM, Qureshi AA, Li VW, et al. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011;165(6):1244–50.

    Article  CAS  PubMed  Google Scholar 

  36. Hammer P, Latour E, Bohnett MC, et al. The utility and challenges of histopathologic evaluation in the diagnosis of nonmalignant skin ulcers. Wound Repair Regen. 2020;28(2):219–23.

    Article  PubMed  Google Scholar 

  37. Min MS, Kus K, Wei N, et al. Evaluating the role of histopathology in diagnosing pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicentre, retrospective cohort study. Br J Dermatol. 2022;186(6):1035–7.

    Article  PubMed  Google Scholar 

  38. Ji-Xu A, Liakos W, Merleev A, et al. Assessing the discriminatory ability of diagnostic criteria for ulcerative pyoderma gangrenosum and its mimickers. JAMA Dermatol. 2023;159(3):337–8.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Hodson EL, Salem I, Birkner M, et al. Real-world use of a deep convolutional neural network to assist in the diagnosis of pyoderma gangrenosum. JAAD Case Rep. 2023;38:8–10.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Birkner M, Schalk J, von den Driesch P, Schultz ES. Computer-assisted differential diagnosis of pyoderma gangrenosum and venous ulcers with deep neural networks. J Clin Med. 2022;11(23):7103. https://doi.org/10.3390/jcm11237103.

  41. Janowska A, Davini G, Romanelli M, et al. The Association between pH and fluorescence as noninvasive diagnostic tools in chronic wounds. Int J Low Extrem Wounds. 2023;22(3):454–8.

    Article  CAS  PubMed  Google Scholar 

  42. MacLeod BG, Klarich CS, Wessman LL, et al. Fluorescent imaging as a component of diagnosing pyoderma gangrenosum: a case report. Adv Skin Wound Care. 2022;35(6):1–6.

    Article  PubMed  Google Scholar 

  43. Granieri G, Michelucci A, Manzo Margiotta F, et al. The Role of ultra-high-frequency ultrasound in pyoderma gangrenosum: new insights in pathophysiology and diagnosis. Diagnostics (Basel). 2023;13(17):2802. https://doi.org/10.3390/diagnostics13172802.

  44. Goldust M, Hagstrom EL, Rathod D, et al. Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum. Expert Rev Clin Pharmacol. 2020;13(2):157–61.

    Article  CAS  PubMed  Google Scholar 

  45. Papi M, Papi C. Vasculitic ulcers. Int J Low Extrem Wounds. 2016;15(1):6–16.

    Article  PubMed  Google Scholar 

  46. Sunderkötter CH, Zelger B, Chen KR, et al. Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheumatol. 2018;70(2):171–84.

    Article  PubMed  Google Scholar 

  47. Shakshouk H, Gibson LE. Cutaneous manifestations of ANCA-associated vasculitis: a retrospective review of 211 cases with emphasis on clinicopathologic correlation and ANCA status. Int J Dermatol. 2023;62(2):231–8.

    Article  PubMed  Google Scholar 

  48. Frumholtz L, Laurent-Roussel S, Aumaître O, et al. Clinical and pathological significance of cutaneous manifestations in ANCA-associated vasculitides. Autoimmun Rev. 2017;16(11):1138–46.

    Article  PubMed  Google Scholar 

  49. Marzano AV, Raimondo MG, Berti E, et al. Cutaneous manifestations of ANCA-associated small vessels vasculitis. Clin Rev Allergy Immunol. 2017;53(3):428–38.

    Article  PubMed  Google Scholar 

  50. Montero-Vilchez T, Martinez-Lopez A, Salvador-Rodriguez L, et al. Cutaneous manifestations of granulomatosis with polyangiitis: a case series study. Acta Derm Venereol. 2020;100(10):adv00150.

    Article  CAS  PubMed  Google Scholar 

  51. Sablé-Fourtassou R, Cohen P, Mahr A, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med. 2005;143(9):632–8.

    Article  PubMed  Google Scholar 

  52. Daoud MS, Hutton KP, Gibson LE. Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br J Dermatol. 1997;136(5):706–13.

    Article  CAS  PubMed  Google Scholar 

  53. Golstein S, Delguste T, Vandergheynst F, et al. Rapid-onset bilateral scalp ulceration with visual loss. JAAD Case Rep. 2022;28:97–9.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Shavit E, Marzano AV, Alavi A. Ulcerative versus non-ulcerative panniculitis: is it time for a novel clinical approach to panniculitis? Int J Dermatol. 2021;60(4):407–17.

    Article  PubMed  Google Scholar 

  55. Gibson LE, Specks U, Homburger H. Clinical utility of ANCA tests for the dermatologist. Int J Dermatol. 2003;42(11):859–69.

    Article  PubMed  Google Scholar 

  56. Guchelaar NAD, Waling MM, Adhin AA, et al. The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis. Autoimmun Rev. 2021;20(1):102716.

    Article  CAS  PubMed  Google Scholar 

  57. Stanson AW, Friese JL, Johnson CM, et al. Polyarteritis nodosa: spectrum of angiographic findings. Radiographics. 2001;21(1):151–9.

    Article  CAS  PubMed  Google Scholar 

  58. Bruce AJ, Bennett DD, Lohse CM, et al. Lipodermatosclerosis: review of cases evaluated at Mayo Clinic. J Am Acad Dermatol. 2002;46(2):187–92.

    Article  PubMed  Google Scholar 

  59. Savushkina NM, Egorova ON, Glukhova SI, et al. Panniculitis in rheumatology: features of course and outcomes. Ter Arkh. 2018;90(5):55–60.

    CAS  PubMed  Google Scholar 

  60. Fleischmajer R, Nedwich A. Generalized morphea. I. Histology of the dermis and subcutaneous tissue. Arch Dermatol. 1972;106(4):509–14.

    Article  CAS  PubMed  Google Scholar 

  61. Watanabe T, Tsuchida T. Classification of lupus erythematosus based upon cutaneous manifestations: dermatological, systemic and laboratory findings in 191 patients. Dermatology. 1995;190(4):277–83.

    Article  CAS  PubMed  Google Scholar 

  62. Rangel LK, Villa-Ruiz C, Lo K, et al. Clinical characteristics of lupus erythematosus panniculitis/profundus: a retrospective review of 61 patients. JAMA Dermatol. 2020;156(11):1264–6.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Morita T, Trés GFS, García MSC, et al. Panniculitides of particular interest to the rheumatologist. Adv Rheumatol. 2019;59(1):35.

    Article  PubMed  Google Scholar 

  64. Bosisio F, Boi S, Caputo V, et al. Lobular panniculitic infiltrates with overlapping histopathologic features of lupus panniculitis (lupus profundus) and subcutaneous T-cell lymphoma: a conceptual and practical dilemma. Am J Surg Pathol. 2015;39(2):206–11.

    Article  PubMed  Google Scholar 

  65. Peters MS, Su WP. Lupus erythematosus panniculitis. Med Clin N Am. 1989;73(5):1113–26.

    Article  CAS  PubMed  Google Scholar 

  66. Willemze R, Jansen PM, Cerroni L, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111(2):838–45.

    Article  CAS  PubMed  Google Scholar 

  67. Calderon LM, Pope JE. Scleroderma epidemiology update. Curr Opin Rheumatol. 2021;33(2):122–7.

    Article  PubMed  Google Scholar 

  68. Pope JE, Denton CP, Johnson SR, et al. State-of-the-art evidence in the treatment of systemic sclerosis. Nat Rev Rheumatol. 2023;19(4):212–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Herrick AL, Assassi S, Denton CP. Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need. Nat Rev Rheumatol. 2022;18(5):276–85.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Pagani K, Lukac D, Bhukhan A, et al. Cutaneous manifestations of inflammatory bowel disease: a basic overview. Am J Clin Dermatol. 2022;23(4):481–97.

    Article  PubMed  Google Scholar 

  71. Palamaras I, El-Jabbour J, Pietropaolo N, et al. Metastatic Crohn's disease: a review. J Eur Acad Dermatol Venereol. 2008;22(9):1033–43.

    Article  CAS  PubMed  Google Scholar 

  72. Albertini JG, Tyler W, Miller OF 3rd. Ulcerative sarcoidosis: case report and review of the literature. Arch Dermatol. 1997;133(2):215–9.

    Article  CAS  PubMed  Google Scholar 

  73. Yoo SS, Mimouni D, Nikolskaia OV, et al. Clinicopathologic features of ulcerative-atrophic sarcoidosis. Int J Dermatol. 2004;43(2):108–12.

    Article  PubMed  Google Scholar 

  74. Noiles K, Beleznay K, Crawford RI, et al. Sarcoidosis can present with necrotizing granulomas histologically: two cases of ulcerated sarcoidosis and review of the literature. J Cutan Med Surg. 2013;17(6):377–83.

    Article  PubMed  Google Scholar 

  75. Reid SD, Ladizinski B, Lee K, et al. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options. J Am Acad Dermatol. 2013;69(5):783–91.

    Article  PubMed  Google Scholar 

  76. Lowitt MH, Dover JS. Necrobiosis lipoidica. J Am Acad Dermatol. 1991;25(5 Pt 1):735–48.

    Article  CAS  PubMed  Google Scholar 

  77. Muller SA, Winkelmann RK. Necrobiosis lipoidica diabeticorum: a clinical and pathological investigation of 171 cases. Arch Dermatol. 1966;93(3):272–81.

    Article  CAS  PubMed  Google Scholar 

  78. Hines A, Butterfield R, Boudreaux B, et al. Characteristics of ulcerated and non-ulcerated necrobiosis lipoidica. Int J Dermatol. 2023;62(6):790–6.

    Article  CAS  PubMed  Google Scholar 

  79. Jorizzo JL, Olansky AJ, Stanley RJ. Superficial ulcerating necrobiosis in rheumatoid arthritis: a variant of the necrobiosis lipoidica-rheumatoid nodule spectrum? Arch Dermatol. 1982;118(4):255–9.

    Article  CAS  PubMed  Google Scholar 

  80. Peyrí J, Moreno A, Marcoval J. Necrobiosis lipoidica. Semin Cutan Med Surg. 2007;26(2):87–9.

    Article  PubMed  Google Scholar 

  81. Erfurt-Berge C, Seitz AT, Rehse C, et al. Update on clinical and laboratory features in necrobiosis lipoidica: a retrospective multicentre study of 52 patients. Eur J Dermatol. 2012;22(6):770–5.

    Article  CAS  PubMed  Google Scholar 

  82. Stanway A, Rademaker M, Newman P. Healing of severe ulcerative necrobiosis lipoidica with cyclosporin. Australas J Dermatol. 2004;45(2):119–22.

    Article  PubMed  Google Scholar 

  83. Fay CJ, Iriarte C, Moslehi D, et al. Ulcerating necrobiotic xanthogranuloma: A clinical sign to reconsider progression from MGUS to multiple myeloma. JAAD Case Rep. 2023;40:1–3.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Ferringer T, Miller F 3rd. Cutaneous manifestations of diabetes mellitus. Dermatol Clin. 2002;20(3):483–92.

    Article  PubMed  Google Scholar 

  85. Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus: a review. Endocrinol Metab Clin North Am. 2013;42(4):869–98.

    Article  PubMed  Google Scholar 

  86. Jfri A, Nassim D, O’Brien E, et al. Prevalence of hidradenitis suppurativa: a systematic review and meta-regression analysis. JAMA Dermatology. 2021;157(8):924–31.

    Article  PubMed  Google Scholar 

  87. Von Der Werth J, Williams H. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2000;14(5):389–92.

    Article  PubMed  Google Scholar 

  88. Ring HC, Emtestam L. The microbiology of hidradenitis suppurativa. Dermatol Clin. 2016;34(1):29–35.

    Article  CAS  PubMed  Google Scholar 

  89. Langan EA, Recke A, Bokor-Billmann T, et al. The Role of the cutaneous microbiome in hidradenitis suppurativa—light at the end of the microbiological tunnel. International Journal of Molecular Sciences. 2020;21(4):1205.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Chopra D, Arens RA, Amornpairoj W, et al. Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation. Front Immunol. 2022;13:960488. https://doi.org/10.3389/fimmu.2022.960488.

  91. van Straalen KR, Prens EP, Gudjonsson JE. Insights into hidradenitis suppurativa. J Allergy Clin Immunol. 2022;149(4):1150–61.

    Article  PubMed  Google Scholar 

  92. Pink A, Anzengruber F, Navarini AA. Acne and hidradenitis suppurativa. Br J Dermatol. 2018;178(3):619–31.

    Article  CAS  PubMed  Google Scholar 

  93. Siroy A, Wasman J. Metastatic Crohn disease: a rare cutaneous entity. Arch Pathol Lab Med. 2012;136(3):329–32.

    Article  PubMed  Google Scholar 

  94. Attanoos RL, Appleton MA, Hughes LE, et al. Granulomatous hidradenitis suppurativa and cutaneous Crohn's disease. Histopathology. 1993;23(2):111–5.

    Article  CAS  PubMed  Google Scholar 

  95. Katz RD, Goldberg NH. Marjolin ulcer arising within hidradenitis: a case report and literature review. Ann Plast Surg. 2009;62(2):173–4.

    Article  CAS  PubMed  Google Scholar 

  96. Hsiao JL, Antaya RJ, Berger T, et al. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review. Arch Dermatol. 2010;146(11):1265–70.

    Article  PubMed  Google Scholar 

  97. Strong Rodrigues K, Oliveira-Ribeiro C, de Abreu Fiuza Gomes S, et al. Cutaneous graft-versus-host disease: diagnosis and treatment. Am J Clin Dermatol. 2018;19(1):33–50.

    Article  PubMed  Google Scholar 

  98. Jachiet M, de Masson A, Peffault de Latour R, et al. Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity. British Journal of Dermatology. 2014;171(1):63–8.

    Article  CAS  PubMed  Google Scholar 

  99. Saliba RM, de Lima M, Giralt S, et al. Hyperacute GVHD: risk factors, outcomes, and clinical implications. Blood. 2007;109(7):2751–8.

    Article  CAS  PubMed  Google Scholar 

  100. Jagasia MH, Greinix HT, Arora M, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: i. the 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21(3):389–401.e1.

    Article  PubMed  Google Scholar 

  101. Fowler VG, Durack DT, Selton-Suty C, et al. The 2023 Duke-international society for cardiovascular infectious diseases criteria for infective endocarditis: updating the modified duke criteria. Clin Infect Dis. 2023;77(4):518–26.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Gomes RT, Tiberto LR, Bello VN, et al. Dermatologic manifestations of infective endocarditis. An Bras Dermatol. 2016;91(5 suppl 1):92–4.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Gogos C, Moschovidis V, Adamopoulos C, et al. A case series of skin manifestations of infective endocarditis in contemporary era: just another book finding or a useful clinical sign? Eur Heart J Case Rep. 2021;5(9):ytab345.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Van Gool IC, Kers J, Bakker JA, et al. Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature. Clin Rheumatol. 2022;41(10):2949–60.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Ozkok A. Cholesterol-embolization syndrome: current perspectives. Vasc Health Risk Manag. 2019;15:209–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Byramji A, Gilbert JD, Byard RW. Sudden death as a complication of bacterial endocarditis. Am J Forensic Med Pathol. 2011;32(2):140–2.

    Article  PubMed  Google Scholar 

  107. Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology. 1987;38(10):769–84.

    Article  CAS  PubMed  Google Scholar 

  108. Siow W, Chana J, Pawson R, et al. Type 1 cryoglobulinaemia leading to gangrene of the toes and ischaemic ulceration. Br J Haematol. 2018;181(6):724.

    Article  PubMed  Google Scholar 

  109. Trautmann A, Seitz CS. The complex clinical picture of side effects to anticoagulation. Med Clin N Am. 2010;94(4):821–34 (xii–iii).

    Article  CAS  PubMed  Google Scholar 

  110. Steuer AB, Cohen JM. The color of skin: purple diseases of the skin, nails, and mucosa. Clin Dermatol. 2019;37(5):528–47.

    Article  PubMed  Google Scholar 

  111. Rick J, Strowd L, Pasieka HB, et al. Calciphylaxis: Part I. Diagnosis and pathology. J Am Acad Dermatol. 2022;86(5):973–82.

    Article  CAS  PubMed  Google Scholar 

  112. McCarthy JT, et al. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc. 2016;91(10):1384–94.

    Article  PubMed  Google Scholar 

  113. Hayashi M. Calciphylaxis: diagnosis and clinical features. Clin Exp Nephrol. 2013;17(4):498–503.

    Article  CAS  PubMed  Google Scholar 

  114. Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018;378(18):1704–14.

    Article  CAS  PubMed  Google Scholar 

  115. Dobry AS, Nguyen ED, Shah R, et al. The role of skin biopsy in diagnosis and management of calciphylaxis: A retrospective analysis. Journal of the American Academy of Dermatology. 2021;85(3):765–7.

    Article  PubMed  Google Scholar 

  116. Vuerstaek J, Reeder S, Henquet C, et al. Arteriolosclerotic ulcer of Martorell. Journal of the European Academy of Dermatology and Venereology. 2010;24(8):867–74.

    Article  CAS  PubMed  Google Scholar 

  117. Hafner J, Nobbe S, Partsch H, et al. Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol. 2010;146(9):961–8.

    Article  PubMed  Google Scholar 

  118. Mansour M, Alavi A. Martorell ulcer: chronic wound management and rehabilitation. Chronic Wound Care Manag Res. 2019;6(null):83–8.

    Article  Google Scholar 

  119. Alavi A, Mayer D, Hafner J, et al. Martorell hypertensive ischemic leg ulcer: an underdiagnosed Entity©. Adv Skin Wound Care. 2012;25(12):563–72; quiz 73–4.

    Article  PubMed  Google Scholar 

  120. Kolios AGA, Hafner J, Luder C, et al. Comparison of pyoderma gangrenosum and Martorell hypertensive ischaemic leg ulcer in a Swiss cohort. Br J Dermatol. 2018;178(2):e125–e6.

    Article  CAS  PubMed  Google Scholar 

  121. Alegre VA, Gastineau DA, Winkelmann RK. Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol. 1989;120(3):419–29.

    Article  CAS  PubMed  Google Scholar 

  122. Cañas CA, Durán CE, Bravo JC, et al. Leg ulcers in the antiphospholipid syndrome may be considered as a form of pyoderma gangrenosum and they respond favorably to treatment with immunosuppression and anticoagulation. Rheumatol Int. 2010;30(9):1253–7.

    Article  PubMed  Google Scholar 

  123. Giannakopoulos B, Passam F, Ioannou Y, et al. How we diagnose the antiphospholipid syndrome. Blood. 2009;113(5):985–94.

    Article  CAS  PubMed  Google Scholar 

  124. Alavi A, Hafner J, Dutz JP, et al. Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. J Am Acad Dermatol. 2013;69(6):1033–42.e1.

    Article  PubMed  Google Scholar 

  125. Di Giacomo TB, Hussein TP, Souza DG, et al. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs-a prospective study. J Eur Acad Dermatol Venereol. 2010;24(11):1340–6.

    Article  PubMed  Google Scholar 

  126. Seguí M, Llamas-Velasco M. A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy. Front Med (Lausanne). 2022;9: 993515.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Kavanagh PL, Fasipe TA, Wun T. Sickle cell disease: a review. JAMA. 2022;328(1):57–68.

    Article  CAS  PubMed  Google Scholar 

  128. Trent JT, Kirsner RS. Leg ulcers in sickle cell disease. Adv Skin Wound Care. 2004;17(8):410–6.

    Article  PubMed  Google Scholar 

  129. Eckman JR. Leg ulcers in sickle cell disease. Hematol Oncol Clin N Am. 1996;10(6):1333–44.

    Article  CAS  Google Scholar 

  130. Koshy M, Entsuah R, Koranda A, et al. Leg ulcers in patients with sickle cell disease. Blood. 1989;74(4):1403–8.

    Article  CAS  PubMed  Google Scholar 

  131. Alavi A, Kirsner RS. Hemoglobinopathies and leg ulcers. Int J Low Extrem Wounds. 2015;14(3):213–6.

    Article  PubMed  Google Scholar 

  132. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 1993;29(2 Pt 1):228–36.

    Article  CAS  PubMed  Google Scholar 

  133. Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients. J Am Acad Dermatol. 1990;22(1):19–26.

    Article  CAS  PubMed  Google Scholar 

  134. Hu SC, Chen GS, Wu CS, et al. Rates of cutaneous metastases from different internal malignancies: experience from a Taiwanese medical center. J Am Acad Dermatol. 2009;60(3):379–87.

    Article  PubMed  Google Scholar 

  135. Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol. 1995;33(2 Pt 1):161–82 (quiz 183–6).

    Article  CAS  PubMed  Google Scholar 

  136. Hu SC, Chen GS, Lu YW, et al. Cutaneous metastases from different internal malignancies: a clinical and prognostic appraisal. J Eur Acad Dermatol Venereol. 2008;22(6):735–40.

    Article  PubMed  Google Scholar 

  137. Corbett BE, BN, Markova A. comprehensive wound care for malignant wounds. In: M.H. Alavi A, editors. Local wound care for dermatologists: updates in clinical dermatology. Springer; 2020.

  138. Maida V, Ennis M, Kuziemsky C et al. Symptoms associated with malignant wounds: a prospective case series. J Pain Symptom Manage. 2009;37(2):206–11. https://doi.org/10.1016/j.jpainsymman.2008.01.009.

    Article  PubMed  Google Scholar 

  139. Kanth AM, Heiman AJ, Nair L, et al. Current trends in management of marjolin's ulcer: a systematic review. J Burn Care Res. 2021;42(2):144–51.

    Article  PubMed  Google Scholar 

  140. Thomson J, Hogan S, Leonardi-Bee J, et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2020;11(11):Cd003412.

    PubMed  Google Scholar 

  141. Meaume S, Fromantin I, Teot L. Neoplastic wounds and degenerescence. J Tissue Viability. 2013;22(4):122–30.

    Article  CAS  PubMed  Google Scholar 

  142. Gjødsbøl K, Christensen JJ, Karlsmark T, et al. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J. 2006;3(3):225–31.

    Article  PubMed  PubMed Central  Google Scholar 

  143. Vaiman M, et al. Ecthyma gangrenosum and ecthyma-like lesions: review article. Eur J Clin Microbiol Infect Dis. 2015;34(4):633–9.

    Article  CAS  PubMed  Google Scholar 

  144. Franco-Paredes C, Marcos LA, Henao-Martínez AF, et al. Cutaneous mycobacterial infections. Clin Microbiol Rev. 2018;32(1):e00069–18. https://doi.org/10.1128/CMR.00069-18.

  145. Oranges T, Veraldi S, Granieri G, et al. Parasites causing cutaneous wounds: Theory and practice from a dermatological point of view. Acta Tropica. 2022;228:106332.

    Article  CAS  PubMed  Google Scholar 

  146. Shields BE, Rosenbach M, Brown-Joel Z, et al. Angioinvasive fungal infections impacting the skin: Background, epidemiology, and clinical presentation. J Am Acad Dermatol. 2019;80(4):869–80.e5.

    Article  PubMed  Google Scholar 

  147. Ge Y, Wang Q. Current research on fungi in chronic wounds. Front Mol Biosci. 2022;9:1057766.

    Article  CAS  PubMed  Google Scholar 

  148. Pradhan S, Sirka CS, Panda M, et al. Lues Maligna in an Immunocompetent Female. Indian Dermatol Online J. 2018;9(5):344–6.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Chatterjee D, Saikia UN, Ramesh V. Diagnostic dilemma of cutaneous tuberculosis: opening of the Pandora’s box. Am J Dermatopathol. 2021;43(12):871–80.

    Article  PubMed  Google Scholar 

  150. Gardini G, Gregori N, Matteelli A, et al. Mycobacterial skin infection. Curr Opin Infect Dis. 2022;35(2):79–87.

    Article  PubMed  PubMed Central  Google Scholar 

  151. Fevereiro J, Sajjadi N, Fraga AG, et al. Individual and clinical variables associated with the risk of Buruli ulcer acquisition: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2020;14(4):e0008161.

    Article  PubMed  PubMed Central  Google Scholar 

  152. Gardner SE, Hillis SL, Heilmann K, et al. The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes. 2013;62(3):923–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  153. Loesche M, Gardner SE, Kalan L, et al. Temporal stability in chronic wound microbiota is associated with poor healing. J Invest Dermatol. 2017;137(1):237–44.

    Article  CAS  PubMed  Google Scholar 

  154. Kasim J, Wanat KA. Tzanck smear of ulcerated plaques. JAMA Dermatol. 2023;159(12):1387–8.

    Article  PubMed  Google Scholar 

  155. Ortega-Loayza AG, McCall CO. Images in clinical medicine: cutaneous blastomycosis. N Engl J Med. 2013;368(10): e13.

    Article  PubMed  Google Scholar 

  156. Gattringer C, Scheurecker C, Höpfl R, et al. Association between venous leg ulcers and sex chromosome anomalies in men. Acta Derm Venereol. 2010;90(6):612–5.

    Article  PubMed  Google Scholar 

  157. Fine JD. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the National Epidermolysis Bullosa Registry. JAMA Dermatol. 2016;152(11):1231–8.

    Article  PubMed  Google Scholar 

  158. Tang JY, Marinkovich MP, Lucas E, et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet J Rare Dis. 2021;16(1):175.

    Article  PubMed  PubMed Central  Google Scholar 

  159. Sangha N, MacLellan AN, Pope E. Psychosocial impact of epidermolysis bullosa on patients: a qualitative study. Pediatr Dermatol. 2021;38(4):819–24.

    Article  PubMed  Google Scholar 

  160. Mauritz PJ, Bolling M, Duipmans JC, et al. Patients' and parents' experiences during wound care of epidermolysis bullosa from a dyadic perspective: a survey study. Orphanet J Rare Dis. 2022;17(1):313.

    Article  PubMed  PubMed Central  Google Scholar 

  161. Bruckner AL, Losow M, Wisk J, et al. The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers. Orphanet J Rare Dis. 2020;15(1):1.

    Article  PubMed  PubMed Central  Google Scholar 

  162. South AP, Laimer M, Gueye M, et al. Type VII collagen deficiency in the oncogenesis of cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa. J Invest Dermatol. 2023;143(11):2108–19.

    Article  CAS  PubMed  Google Scholar 

  163. D'Epiro S, Salvi M, Luzi A, et al. Drug cutaneous side effect: focus on skin ulceration. Clin Ter. 2014;165(4):e323–9.

    CAS  PubMed  Google Scholar 

  164. Wei KC, Yang KC, Mar GY, et al. STROBE-radiation ulcer: an overlooked complication of fluoroscopic intervention: a cross-sectional study. Medicine (Baltimore). 2015;94(48):e2178.

    Article  CAS  PubMed  Google Scholar 

  165. Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol. 2006;54(1):28–46.

    Article  PubMed  Google Scholar 

  166. Hegedus F, Mathew LM, Schwartz RA. Radiation dermatitis: an overview. Int J Dermatol. 2017;56(9):909–14.

    Article  PubMed  Google Scholar 

  167. Duron D, Blaise S, Cracowski J-L, et al. Drug-induced skin ulcers: A disproportionality analysis from the WHO pharmacovigilance database. Journal of the American Academy of Dermatology. 2021;85(1):229–32.

    Article  PubMed  Google Scholar 

  168. Zhang M, Hassan KM, Musiek A, et al. Ponatinib-induced neutrophilic panniculitis. J Cutan Pathol. 2014;41(7):597–601.

    Article  CAS  PubMed  Google Scholar 

  169. Stewart J, Bayers S, Vandergriff T. Self-limiting ibrutinib-induced neutrophilic panniculitis. Am J Dermatopathol. 2018;40(2):e28–9.

    Article  PubMed  Google Scholar 

  170. Wu BC, Patel ED, Ortega-Loayza AG. Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum. Br J Dermatol. 2017;177(1):72–83.

    Article  CAS  PubMed  Google Scholar 

  171. Gormley R, Wanat K, Elenitsas R, et al. Ipilimumab-associated Sweet syndrome in a melanoma patient. J Am Acad Dermatol. 2014;71(5):e211–3.

    Article  PubMed  Google Scholar 

  172. Adler NR, Murray WK, Brady B, et al. Sweet syndrome associated with ipilimumab in a patient with metastatic melanoma. Clin Exp Dermatol. 2018;43(4):497–9.

    Article  CAS  PubMed  Google Scholar 

  173. Kyllo RL, Parker MK, Rosman I, et al. Ipilimumab-associated Sweet syndrome in a patient with high-risk melanoma. J Am Acad Dermatol. 2014;70(4):e85–e6.

    Article  PubMed  Google Scholar 

  174. Pintova S, Sidhu H, Friedlander PA, et al. Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy. Melanoma Res. 2013;23(6):498–501.

    Article  PubMed  Google Scholar 

  175. Soslow Z, Monterroso K. City of Philadelphia overdose fatality review. OD STAT. 2021. https://www.phila.gov/media/20220713130058/OD-Stat-Annual-Report-2021-FINAL.pdf.

  176. Wei J, Wachuku C, Berk-Krauss J, et al. Severe cutaneous ulcerations secondary to xylazine (tranq): A case series. JAAD Case Reports. 2023;36:89–91.

    Article  PubMed  PubMed Central  Google Scholar 

  177. Harth W, Taube K-M, Gieler U. Facticious disorders in dermatology. JDDG. 2010;8(5):361–73.

    PubMed  Google Scholar 

  178. Uçmak D, Harman M, Akkurt ZM. Dermatitis artefacta: a retrospective analysis. Cutan Ocul Toxicol. 2014;33(1):22–7.

    Article  PubMed  Google Scholar 

  179. Van Moffaert M. Training future dermatologists in psychodermatology. Gen Hosp Psychiatry. 1986;8(2):115–8.

    Article  PubMed  Google Scholar 

  180. Khan AU, Khachemoune A. Trigeminal trophic syndrome: an updated review. Int J Dermatol. 2019;58(5):530–7.

    Article  PubMed  Google Scholar 

  181. Rashid RM, Khachemoune A. Trigeminal trophic syndrome. J Eur Acad Dermatol Venereol. 2007;21(6):725–31.

    Article  CAS  PubMed  Google Scholar 

  182. Sawada T, Asai J, Nomiyama T, et al. Trigeminal trophic syndrome: report of a case and review of the published work. J Dermatol. 2014;41(6):525–8.

    Article  PubMed  Google Scholar 

  183. Alivernini S, De Santis M, Tolusso B, et al. Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing. J Am Acad Dermatol. 2009;60(3):426–35.

    Article  PubMed  Google Scholar 

  184. Ayello EA. What does the wound say? Why determining etiology is essential for appropriate wound care. Adv Skin Wound Care. 2005;18(2):98–109 (quiz 110–1).

    Article  PubMed  Google Scholar 

  185. Dissemond J, Romanelli M. Inflammatory skin diseases and wounds. Br J Dermatol. 2022;187(2):167–77.

    Article  PubMed  Google Scholar 

  186. Keast DH, Bowering CK, Evans AW, et al. MEASURE: A proposed assessment framework for developing best practice recommendations for wound assessment. Wound Repair Regen. 2004;12(3 Suppl):S1–17.

    PubMed  Google Scholar 

  187. Falanga V. Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen. 2000;8(5):347–52.

    Article  CAS  PubMed  Google Scholar 

  188. Sibbald RG, Williamson D, Orsted HL, et al. Preparing the wound bed-debridement, bacterial balance, and moisture balance. Ostomy Wound Manage. 2000;46(11):14–22, 4–8, 30–5; quiz 6–7.

    CAS  Google Scholar 

  189. Atkin L, Bućko Z, Montero EC, et al. Implementing TIMERS: the race against hard-to-heal wounds. J Wound Care. 2019;28(Sup3a):S1–50.

    Article  Google Scholar 

  190. Woo KY. Management of non-healable or maintenance wounds with topical povidone iodine. Int Wound J. 2014;11(6):622–6.

    Article  PubMed  Google Scholar 

  191. Hines A, Kody S, Shakshouk H, et al. Inflammatory and vaso-occlusive ulcers: Part II - Management. J Am Acad Dermatol. 2024.

  192. Moelleken M, Krimphove SH, Krefting F, et al. How effective is simple mechanical wound debridement in reducing bacterial colonisation? Results of a prospective clinical study. Int Wound J. 2024;21(4):e14824.

    Article  PubMed  PubMed Central  Google Scholar 

  193. Dissemond J, Eder S, Läuchli S, et al. [Compression therapy for inflammatory dermatoses of the legs]. Dtsch Med Wochenschr. 2024;149(3):106–12.

    PubMed  Google Scholar 

  194. Chen AH, Frangos SG, Kilaru S, et al. Intermittent pneumatic compression devices - physiological mechanisms of action. Eur J Vasc Endovasc Surg. 2001;21(5):383–92.

    Article  CAS  PubMed  Google Scholar 

  195. Conde-Montero E, Dissemond J, Protz K. Compression Therapy in Dermatology. Terapia compresiva en Dermatología. Actas Dermosifiliogr. 2024. https://doi.org/10.1016/j.ad.2024.02.015.

  196. Stevenson EM, Coda A, Bourke MDJ. Investigating low rates of compliance to graduated compression therapy for chronic venous insufficiency: a systematic review. Int Wound J. 2024;21(4): e14833.

    Article  PubMed  PubMed Central  Google Scholar 

  197. Snyder DSN, Margolis D, et al. Skin substitutes for treating chronic wounds. Rockville: Agency for Healthcare Research and Quality; 2020.

    Google Scholar 

  198. Sierra-Sánchez Á, Kim KH, Blasco-Morente G, et al. Cellular human tissue-engineered skin substitutes investigated for deep and difficult to heal injuries. NPJ Regen Med. 2021;6(1):35.

    Article  PubMed  PubMed Central  Google Scholar 

  199. Kranke P, Bennett MH, Martyn-St James M, et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015;2015(6):Cd004123.

    PubMed  PubMed Central  Google Scholar 

  200. Bennett MH, Feldmeier J, Hampson NB, et al. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2016;4(4):Cd005005.

    PubMed  Google Scholar 

  201. Orgill DP, Manders EK, Sumpio BE, et al. The mechanisms of action of vacuum assisted closure: more to learn. Surgery. 2009;146(1):40–51.

    Article  PubMed  Google Scholar 

  202. Eisendle K, Thuile T, Deluca J, et al. Surgical treatment of pyoderma gangrenosum with negative pressure wound therapy and skin grafting, including xenografts: personal experience and comprehensive review on 161 cases. Adv Wound Care (New Rochelle). 2020;9(7):405–25.

    Article  PubMed  PubMed Central  Google Scholar 

  203. Erickson KM, Kody S, Ortega-Loayza AG. Pain as a patient-reported outcome measure in pyoderma gangrenosum. JAMA Dermatol. 2023;159(11):1274–5.

    Article  PubMed  Google Scholar 

  204. Beiteke U, Bigge S, Reichenberger C, et al. Pain and pain management in dermatology. J Dtsch Dermatol Ges. 2015;13(10):967–87.

    PubMed  Google Scholar 

  205. Janowska A, Papa G, Romanelli M, et al. 5% Lidocaine hydrochloride cream for wound pain relief: a multicentre observational study. J Invest Surg. 2022;35(1):49–52.

    Article  PubMed  Google Scholar 

  206. de Leon J, Bohn GA, DiDomenico L, et al. Wound care centers: critical thinking and treatment strategies for wounds. Wounds. 2016;28(10):S1–23.

    PubMed  Google Scholar 

  207. Fayne RA, Borda LJ, Egger AN, et al. The potential impact of social genomics on wound healing. Adv Wound Care (New Rochelle). 2020;9(6):325–31.

    Article  PubMed  PubMed Central  Google Scholar 

  208. Pierpont YN, Dinh TP, Salas RE, et al. Obesity and surgical wound healing: a current review. ISRN Obes. 2014;2014:638936.

    PubMed  PubMed Central  Google Scholar 

  209. Mahmoudi MGL. Opportunities and challenges of the management of chronic wounds: a multidisciplinary viewpoint. Chronic Wound Care Manag Res. 2020;7:27–36.

    Article  Google Scholar 

  210. Jung K, Covington S, Sen CK, et al. Rapid identification of slow healing wounds. Wound Repair Regen. 2016;24(1):181–8.

    Article  PubMed  PubMed Central  Google Scholar 

  211. Ahuja S, Briggs SM, Collier SM. Teledermatology in rural, underserved, and isolated environments: a review. Curr Dermatol Rep. 2022;11(4):328–35.

    Article  PubMed  PubMed Central  Google Scholar 

  212. Stojadinovic O, Brem H, Vouthounis C, et al. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol. 2005;167(1):59–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  213. Harrison OJ, Linehan JL, Shih HY, et al. Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury. Science. 2019;363(6422):eaat6280. https://doi.org/10.1126/science.aat6280.

  214. De Pessemier B, Grine L, Debaere M, et al. Gut–Skin Axis: Current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms. 2021;9(2):353.

    Article  PubMed  PubMed Central  Google Scholar 

  215. Rick J, Gould LJ, Marzano AV, et al. The "Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)" Project: a protocol for the development of the core outcome domain set for trials in pyoderma gangrenosum. Arch Dermatol Res. 2023;315(4):983–8.

    Article  PubMed  Google Scholar 

  216. Kohn AH, Alavi A, Armstrong AW, et al. International dermatology outcome measures (IDEOM): report from the 2020 annual meeting. Dermatology. 2022;238(3):430–7.

    Article  PubMed  Google Scholar 

  217. Orfaly VE, Reese AM, Friedman M, et al. Pyoderma gangrenosum study pilot registry: The first step to a better understanding. Wound Repair Regen. 2022;30(3):334–7.

    Article  PubMed  Google Scholar 

  218. Haddadin OM, Jacobson ME, Chen DM, et al. Minimum data set for treatment effectiveness in pyoderma gangrenosum (MIDSTEP): an international protocol of an e-Delphi study to develop a clinical physician-driven treatment effectiveness registry on behalf of the UPGRADE initiative. Arch Dermatol Res. 2023;315(10):2913–9.

    Article  PubMed  Google Scholar 

  219. Patel NP, Granick MS. Wound education: American medical students are inadequately trained in wound care. Ann Plast Surg. 2007;59(1):53–5 (discussion 55).

    Article  CAS  PubMed  Google Scholar 

  220. Patel NP, Granick MS, Kanakaris NK, et al. Comparison of wound education in medical schools in the United States, United kingdom, and Germany. Eplasty. 2008;8:e8.

    PubMed  PubMed Central  Google Scholar 

  221. Khoobyari S, Miller TI, Shinohara MM. Utility of skin biopsy and culture in the diagnosis and classification of chronic ulcers: a single-institution, retrospective study. Am J Dermatopathol. 2019;41(5):343–6.

    Article  PubMed  Google Scholar 

  222. Maverakis E, Marzano AV, Le ST, et al. Pyoderma gangrenosum. Nature Reviews Disease Primers. 2020;6(1):81.

    Article  PubMed  Google Scholar 

  223. Langan SM, Groves RW, Card TR, et al. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol. 2012;132(9):2166–70.

    Article  CAS  PubMed  Google Scholar 

  224. Hashemi DA, Brown-Joel ZO, Tkachenko E, et al. Clinical features and comorbidities of patients with necrobiosis lipoidica with or without diabetes. JAMA Dermatology. 2019;155(4):455–9.

    Article  PubMed  PubMed Central  Google Scholar 

  225. Kirsten N, Petersen J, Hagenström K, et al. Epidemiology of hidradenitis suppurativa in Germany – an observational cohort study based on a multisource approach. Journal of the European Academy of Dermatology and Venereology. 2020;34(1):174–9.

    Article  CAS  PubMed  Google Scholar 

  226. Peoples C, Medsger TA, Jr., Lucas M, et al. Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. J Scleroderma Relat Disord. 2016;1(2):177–240.

    PubMed  Google Scholar 

  227. Fett N, Werth VP. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2011;64(2):217–28.

    Article  PubMed  Google Scholar 

  228. Leitenberger JJ, Cayce RL, Haley RW, et al. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Archives of Dermatology. 2009;145(5):545–50.

    Article  PubMed  PubMed Central  Google Scholar 

  229. Bergamasco A, Hartmann N, Wallace L, et al. Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clin Epidemiol. 2019;11:257–73.

    Article  PubMed  PubMed Central  Google Scholar 

  230. Gardette E, Moguelet P, Bouaziz JD, et al. Livedoid vasculopathy: a french observational study including therapeutic options. Acta Derm Venereol. 2018;98(9):842–7.

    Article  CAS  PubMed  Google Scholar 

  231. Jeong HS, Dominguez AR. Calciphylaxis: controversies in pathogenesis, diagnosis and treatment. Am J Med Sci. 2016;351(2):217–27.

    Article  PubMed  Google Scholar 

  232. Dissemond J, Marzano AV, Hampton PJ, et al. Pyoderma gangrenosum: treatment options. Drugs. 2023;83(14):1255–67.

    Article  PubMed  PubMed Central  Google Scholar 

  233. Yamamoto T, Yamasaki K, Yamanaka K, et al. Clinical guidance of pyoderma gangrenosum 2022. J Dermatol. 2023;50(9):e253–e75.

    Article  PubMed  Google Scholar 

  234. Hellmich B, Sanchez-Alamo B, Schirmer JH, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2024;83(1):30–47.

    Article  PubMed  Google Scholar 

  235. Chung SA, Langford CA, Maz M, et al. 2021 American college of rheumatology/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2021;73(8):1366–83.

    Article  CAS  PubMed  Google Scholar 

  236. Klejtman T, Lazareth I, Yannoutsos A, et al. Specific management of lipodermatosclerosis (sclerotic hypodermitis) in acute and chronic phase. JMV-Journal de Médecine Vasculaire. 2022;47(4):186–90.

    CAS  PubMed  Google Scholar 

  237. Sibbald C, Reid S, Alavi A. Necrobiosis lipoidica. Dermatol Clin. 2015;33(3):343–60.

    Article  CAS  PubMed  Google Scholar 

  238. Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91–101.

    Article  PubMed  PubMed Central  Google Scholar 

  239. Teske N, Fett N. Recent advances in treatment of systemic sclerosis and morphea. Am J Clin Dermatol. 2024;25(2):213–26.

    Article  PubMed  Google Scholar 

  240. Kowal-Bielecka O, Fransen J, Avouac J, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76(8):1327–39.

    Article  PubMed  Google Scholar 

  241. Rick J, Rrapi R, Chand S, et al. Calciphylaxis: Treatment and outlook-CME part II. J Am Acad Dermatol. 2022;86(5):985–92.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Oregon Health & Science University, 3303 S Bond Ave Building 1, 16th Floor, Portland, OR, 97239, USA

    Sarah L. Becker, Shannon Kody, Nicole M. Fett & Alex G. Ortega-Loayza

  2. Department of Dermatology, Mayo Clinic, Rochester, MN, USA

    Alexander Hines & Afsaneh Alavi

Authors
  1. Sarah L. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shannon Kody
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicole M. Fett
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexander Hines
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Afsaneh Alavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alex G. Ortega-Loayza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alex G. Ortega-Loayza.

Ethics declarations

Funding

No funding was received for the preparation of this article.

Conflicts of Interest/Competing Interests

Alex G. Ortega-Loayza is the current President of the Pacific Dermatology Association and serves as an associate editor for Dermatology (Karger) and is a member of the editorial board for the American Journal of Clinical Dermatology. Alex G. Ortega-Loayza was not involved in the selection of peer reviewers for this manuscript nor any of the subsequent editorial decisions. Additionally, he is a consultant for Genentech and Guidepoint and an advisor to Bristol Meyer Squibb, Boehringer Ingelheim, and Janssen. Alex G. Ortega-Loayza has received research grants from Lilly, Janssen, Incyte, and Pfizer and is supported by NIAMS NIH R01 AR083110. Afsaneh Alavi serves as a board member of Hidradenitis Suppurativa Foundation and an associate editor for Dermatology (Karger). She is an investigator for Boehringer Ingelheim and Process, serves on independent data monitoring for Process and CL Behring, and an advisor for Abbvie, Boehringer Ingelheim, CL Behring, Inflarx, Incyte, Kymera, Janssen, Novartis, and UCB. Nicole M. Fett is on the Medical Dermatology Society Board of Directors, is the chair of the Oregon Dermatology Society speakers committee, is an author and editor for UpToDate, and has served as a consultant for Sanofi. Sarah L. Becker, Shannon Kody, and Alexander Hines have no conflicts of interest that are directly relevant to the content of this article.

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Patient consent was obtained for all clinical images.

Availability of Data and Material

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

Code Availability

Not applicable.

Authors’ Contributions

SLB and AGOL were responsible for study conception and design. SLB drafted the main text. AGOL, NF, and SK provided critical revision. All authors have read and approved the final version of the manuscript and agree to be accountable for this work.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Becker, S.L., Kody, S., Fett, N.M. et al. Approach to the Atypical Wound. Am J Clin Dermatol (2024). https://doi.org/10.1007/s40257-024-00865-0

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40257-024-00865-0

Search

Navigation